Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
PEMBROLIZUMAB 790 MG-BERAHYALURONID-PMPH 9 600 UNIT/4.8 ML SUBCUT SOLN (CDM RX-195778) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 5, 2026 , from http://ppman.hank.ai/transparency/procedure/RX-195778/by-state?code_type=CDM
“PEMBROLIZUMAB 790 MG-BERAHYALURONID-PMPH 9 600 UNIT/4.8 ML SUBCUT SOLN (CDM RX-195778) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/RX-195778/by-state?code_type=CDM. Accessed
November 5, 2026 .
“PEMBROLIZUMAB 790 MG-BERAHYALURONID-PMPH 9 600 UNIT/4.8 ML SUBCUT SOLN (CDM RX-195778) by State,” HANK Price Transparency ,
accessed November 5, 2026 ,
http://ppman.hank.ai/transparency/procedure/RX-195778/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
RX-195778 — Pembrolizumab 790 Mg-berahyaluronid-pmph 9 600 Unit/4.8 Ml Subcut Soln
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$67,376
National median
$58,954 – $84,220
IQR (p25 – p75)
2
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for RX-195778 (CDM), with interquartile range
State Median p25 p75
AL $67,376 $58,954 $84,220